Kim Forest Enterprise Co., Ltd. (TPE:6645)

Taiwan · Delayed Price · Currency is TWD

13.50

+1.20 (9.76%)

Oct 8, 2026, 1:24 PM CST

Market Cap	815.18M -41.4%
Revenue (ttm)	599.63M +17.2%
Net Income	-135.68M
EPS	-2.24
Shares Out	60.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.08 (0.62%)
Ex-Dividend Date	n/a

Volume	218,481
Open	13.10
Previous Close	12.30
Day's Range	13.10 - 13.50
52-Week Range	11.40 - 26.45
Beta	-0.05
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 9, 2026

About Kim Forest Enterprise

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2004

Employees 58

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 6645

Full Company Profile

Financial Performance

In 2025, Kim Forest Enterprise's revenue was 549.14 million, an increase of 9.49% compared to the previous year's 501.53 million. Losses were -146.45 million, -8.40% less than in 2024.

Financial Statements